MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$7,498K Other receivables$727K Accountsreceivable-Nonrelated Party$110K Cash and cashequivalents$153,088K Other non-currentassets$5,738K Operating right-of-useasset$6,004K Property and equipment,net$4,306K Total current assets$161,423K Total assets$177,471K Total liabilities andstockholders equity$177,471K Total stockholdersequity$36,830K Total liabilities$140,641K Accumulated deficit-$213,353K Additionalpaid-in-capital$250,182K Non-current portion ofoperating lease liability$4,741K Long-term debt, net$99,917K Total currentliabilities$35,983K Common stock, 0.0001par value...$1K Current portion ofoperating lease liability$2,247K Accrued expenses$26,963K Accounts payable$6,773K
Balance Sheet
source: myfinsight.com

Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX)